000 01497 a2200409 4500
005 20250515214228.0
264 0 _c20100913
008 201009s 0 0 eng d
022 _a1872-8111
024 7 _a10.1016/j.neures.2010.03.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlachkar, Amal
245 0 0 _aBinding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human alpha(2)-adrenergic and dopaminergic receptors.
_h[electronic resource]
260 _bNeuroscience research
_cJul 2010
300 _a245-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xmetabolism
650 0 4 _aBinding, Competitive
_xdrug effects
650 0 4 _aBrain Chemistry
_xdrug effects
650 0 4 _aCHO Cells
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aDopamine
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aLevodopa
_xmetabolism
650 0 4 _aRadioligand Assay
650 0 4 _aReceptors, Adrenergic, alpha-2
_xdrug effects
650 0 4 _aReceptors, Dopamine
_xdrug effects
650 0 4 _aReceptors, Dopamine D1
_xdrug effects
650 0 4 _aReceptors, Dopamine D2
_xdrug effects
650 0 4 _aTransfection
700 1 _aBrotchie, Jonathan M
700 1 _aJones, Owen T
773 0 _tNeuroscience research
_gvol. 67
_gno. 3
_gp. 245-9
856 4 0 _uhttps://doi.org/10.1016/j.neures.2010.03.008
_zAvailable from publisher's website
999 _c19666513
_d19666513